Lily Wound joined Ballard Spahr’s business and transactions department, corporate group, and life sciences industry team as a partner in New York, the firm announced Thursday.
Wound advises companies on complex commercial, licensing, and intellectual property-related transactions. She works on transactions throughout the lifecycle of life sciences products, from early-stage development to commercialization, and advises companies on artificial intelligence, gene therapy, gene editing, and engineered cell therapies, the firm said.
This story was produced by Bloomberg Law Automation.
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.